• 제목/요약/키워드: MLD

검색결과 158건 처리시간 0.025초

비소세포폐암 III, IV기 환자에 있어서 Shell-Type Pseudo Target을 이용한 세기 조절 방사선치료계획기법의 유용성 평가 (Assessment of the Usefulness of an IMRT Plan Using a Shell-Type Pseudo Target with Patients in Stage III or IV of NSCLC)

  • 이상봉;박기주;박두찬;김만우;김준곤;노성환
    • 대한방사선치료학회지
    • /
    • 제24권2호
    • /
    • pp.95-106
    • /
    • 2012
  • 목 적: 비소세포폐암(Non-Small Cell Lung Cancer, NSCLC) III, IV기 환자의 방사선 치료 시 Shell-Type Pseudo Target의 유무에 따른 IMRT 치료계획의 유용성을 알아보고자 한다. 대상 및 방법: NSCLC III, IV기 환자 22명을 대상으로 Shell-Type Pseudo Target이 있을 때와(SPT) Shell-Type Pseudo Target이 없을 때(WSPT) 각각의 세기변조방사선치료(Intensity-Modulated Radiation Therapy, IMRT)계획을 세운 후, 선량-체적 히스토그람(Dose-Volume Histogram, DVH) 분석을 통해 종양 표적 내의 균일성 지수(Homogeneity Index, HI), 종양 표적에 대한 선량조형 지수(Conformity Index, CI), 척수 최대선량(Spinal Cord Maximum Dose), 식도에 대한 $V_{50%}$, 평균 폐 선량(Mean Lung Dose, MLD), 폐에 대한 $V_{40%}$ $V_{30%}$ $V_{20%}$ $V_{10%}$ $V_{5%}$ 등의 선량학적인 비교를 통해서 평가하였다. 결 과: WSPT와 SPT에 따른 각각의 CI 값은 평균 $1.22{\pm}0.04$, $1.16{\pm}0.032$ (.000*), HI 값은 평균 $1.06{\pm}0.015$, $1.07{\pm}0.014$ (.000*)로 나타났으며, CI 값은 SPT의 경우에서 각각의 차이 값에 대한 평균은 $-5.16{\pm}2.54%$의 감소를 보였으며, HI 값은 SPT의 경우에서 평균 $0.81{\pm}0.47%$ 증가된 것으로 나타났다. 식도에 대한 $V_{50%}$에서는 각각 $14.54{\pm}12.01%$ (WSPT), $12.14{\pm}11.09%$ (.000*, SPT)로 SPT에서 차이 값에 대한 평균이 $-26.37{\pm}25.05%$ 감소되었고, 척수 최대선량에서도 평균 선량이 각각 $3,898.44{\pm}1,075.0$ cGy (WSPT), $3,810.8{\pm}1,134.9$ cGy (.004*, SPT)로 SPT의 경우 평균 $-3.36{\pm}5.81%$ 감소되었다. 폐에 대한 $V_{X%}$에서는 $V_{5%}$, $V_{10%}$의 경우 차이 값에 대한 평균이 $-1.62{\pm}2.29%$ (.006*), $-1.98{\pm}5.02%$ (.005*)로 SPT의 경우에서 감소됨을 보여 주었고, 마찬가지로 $V_{20%}$, $V_{30%}$, $V_{40%}$에서도 각각 $-3.51{\pm}3.07%$ (.000*), $-4.84{\pm}6.01%$ (.000*), $-6.16{\pm}8.46%$ (.001*)로 SPT 경우에서 통계학적으로 유의함을 보이면서 감소한 것으로 나타났다. MLD의 평가에서도 SPT의 경우에서 평균 $-2.83{\pm}2.41%$ (.000*)의 감소를 보여주었으며, 이는 평균 169 cGy (Max: 547 cGy, Min: 6.4 cGy)의 처방선량을 SPT 사용 시 올릴 수 있는 결과를 보여주었다. 결 론: NSCLC III, IV기 환자의 방사선 치료 시 SPT를 이용한 IMRT 치료계획이 정상 폐에 들어가는 방사선량을 줄임으로 인해 방사선치료로 유발되는 폐렴의 위험을 감소시킬 수 있을 거라 생각되고, 또한 얼마간의 처방선량 증가로 인한 방사선치료 국소제어실패율을 감소시키는 동시에 치료효과를 증대 시킬 수 있을 것이라 사료된다.

  • PDF

뉴캣슬병 면역에 대한 검토 II. 접종경로를 달리하여 $B_1$ Strain을 응용한 면역효과 검토 (Studies on the Immunization Against Newcastle Disease II. Investigation on the Immune Effect by Different Vaccination Route with $B_1$ Strain)

  • 이학철;정유열
    • 한국가금학회지
    • /
    • 제8권2호
    • /
    • pp.69-75
    • /
    • 1981
  • 본 연구는 오늘날 뉴캣슬병(ND) 예방접종 목적에 널러 쓰여지는 Adjuvant가 불활화예방약과 약독주 생독예방약(LV)의 두가지 중 특히 논의가 많은 LV의 접종경로에 따르는 면역효과를 밝혀. 그 결과를 일반에게 명확히 제시하여 본병방과에 도움을 주는 목적으로 시행하였다. 이 연구를 위해서 먼저 LV생산재료로 사용되는 $B_1$ 접종 발육계묘에서 얻은 장요막질액의 접종경로별 면역력가를 30일영추를 공시하여 측정한 후, 그 유효량을 사용하여 분무, 비강내적하 근육주사, 음수투여의 4가지 경로를 통해서 상기시험일때와 동일하게 30일추에 각각 접종, 접종경로별로 면역효과를 비교 검토하였다. 그리하여 얻어진 결과를 요약하면 다음과 같다. 1. $10^{8.5}$ EI $D_{50}$$m\ell$의 역가를 가진 $B_1$독주장요막강액재료의 10진희척 각단계액을 30일추에 대하여 업종경로별 각소정량을 분무, 비강내적하, 근육주사하였을 때 상기재료의 $10^{-2}$ 희척($10^{6.5}$ EI $D_{50}$$m\ell$) 응용은 만족한 면역성을 부여하였으나 $10^{-3}$희척($10^{5.5}$ EI $D_{50}$$m\ell$)에서는 만족스럽지 못하였으며 I $D_{50}$(-log)는 근육주사=2.8, 분묘>4.1, 비강내적하>4.2이었다. 2. $10^{-2}$ 희포장요막강($10^{6.5}$ EI $D_{50}$$m\ell$)의 접종경로별 각소정량을 30일령 공시추에 접종경로를 달리하여 접종하였을 때 10,000MLD/$m\ell$ ND 병독/$m\ell$의 근육내접종공격에 대한 내과율은 분무가 93.75%, 비강내적하가 95.3%, 근육내접종이 92.6%의 좋은 성적이었는데 반하여 식수투여는 47.18%로 극히 불량하고, 시험한 4가지 접종경로 중 가장 낮은 성적이었다. 낮은 성적이었다.은 성적이었다.

  • PDF

Multiple Low Dose Streptozotocin으로 유도된 당뇨 흰쥐에서 투여 시기에 따른 인삼의 항당뇨 활성 비교 (Comparisons of Antidiabetic Effect of Panax Ginseng on MLD STZ-induced Diabetic rats in Terms of Time of Administration)

  • 박경수;이동억;성종환;정성현
    • Journal of Ginseng Research
    • /
    • 제26권4호
    • /
    • pp.191-195
    • /
    • 2002
  • MLD STZ로 당뇨를 유발시킨 SD rat에서 투여 시기에 따른 백삼의 항당뇨 활성을 비교한 결과를 요약하면 다음과 같다. 1. 동시 투여군은 실험 시작 초반에 체중이 감소하는 듯 하였다가 당뇨 대조군에 비하여 현저히 체중이 증가하였고 후 투여군 역시 백삼의 투여에 의하여 체중이 증가하였다. 2. 동시 투여군에서 STZ 투여 후 초반 7일간 혈당이 상승 하였으나 곧 탁월한 혈당 강하 활성을 나타내었으며 또한 계속적:인 당뇨병의 진행을 막아주었다. 후 투여군에서는 즉각적으로 혈당 강하 활성이 나타났고 이는 투여 종료 시점까지 유지되었다. 3. 동시 투여군과 후 투여군 모두 식이량과 음용수 섭취량을 개선시켜 주었다. 4. 동시 투여군과 후 투여군은 모두 체중 대비 신장 무게의 비를 낮추어 줌으로써 고혈당으로 인해 야기되는 신장비대를 개선시켜 주었다. 5. STZ로 유도된 당뇨 흰쥐에서 백삼이 혈당 강하 활성을 나타내는 것은 췌장 베타세포의 보호 활성과 insulin의 분비 촉진과 관련이 있을 것으로 추측된다. 6. 각 투여군에서 투여 종료시점의 혈당이 당뇨 대조군에 비하여 각각 64%, 67%수준을 나타내어 백삼이 당뇨병이 발생되기 전이나 혹은 당뇨병이 발생된 후에 투여되더라도 우수한 혈당강하 효과를 나타낼 수 있음을 알 수 있었다. 따라서 인삼은 impaired glucose tolerance(IGT)를 나타내는 사람에서 당뇨병의 발병을 예방할 목적으로 투여할수 있을 뿐만 아니라 이미 당뇨병이 발병된 사람에서도 우수한 혈당 강하 활성을 나타내어 치료제로서의 가능성도 보여주었다.

주파수에 따른 감쇠계수 변화량을 이용한 해저 퇴적물 특징 추출 알고리즘 (Seabed Sediment Feature Extraction Algorithm using Attenuation Coefficient Variation According to Frequency)

  • 이기배;김주호;이종현;배진호;이재일;조정홍
    • 전자공학회논문지
    • /
    • 제54권1호
    • /
    • pp.111-120
    • /
    • 2017
  • 본 논문에서는 해저 퇴적물 분류를 위한 특징 추출 기법을 제안하고 검증한다. 기존 연구에서는 주파수의 영향이 없는 반사계수를 이용하여 퇴적물을 분류해 왔다. 그러나 해저 퇴적물의 음향 감쇠계수는 주파수의 함수이며 퇴적 성분에 따라 서로 다른 특성을 나타낸다. 따라서 주파수에 따른 감쇠계수 변화량을 이용하여 특징벡터를 생성하였다. 감쇠계수 변화량은 Chirp 신호에 의해 생성된 두 번째 층 반사신호를 이용하여 추정한다. Chirp 신호의 다중대역 특징이 다차원 벡터를 형성하기 때문에 기존의 방법에 비해 우수한 특성을 갖는다. 반사계수에 의한 분류 성능과 비교하기 위해 선형 판별 분석법 (LDA, Linear Discriminant Analysis)를 이용하여 차원을 축소하였다. Biot 모델을 이용하여 모의실험 환경을 구축하고 Fisher score와 MLD(Maximum Likelihood Decision)를 기반의 분류 정확도를 이용해 제안된 특징을 평가하였다. 그 결과, 제안된 특징은 반사계수에 비해 높은 변별력을 보이며, 측정 및 깊이 추정오차에도 강인한 특성을 보였다.

Multiple Low Dose Streptozotocin으로 유도된 고혈당 흰쥐에서 인삼ㆍ상엽 단독 및 복합 처방의 항당뇨 효과 (Antidiabetic Effects of Ginseng Radix Alba (GRA) and Mori Folium (MF) on Multiple Low Dose Streptozotocin-induced Diabetic Rats)

  • 김소영;윤서현;정성현
    • 약학회지
    • /
    • 제46권6호
    • /
    • pp.411-415
    • /
    • 2002
  • We compared the hypoglycemic effects of Ginseng Radix Alba (GRA) and Mori Folium (MF) in multiple low dose (MLD) streptozotocin(STZ)-induced diabetic rats. In order to induce hyperglycemic state 25 mg/kg of STZ was injected intraperitoneally for 5 consecutive days. SD rats were randomly divided into diabetic control and treatment groups. Treatment groups were administered with either 500 mg/kg of GRA (G500), 500 mg/kg of MF (M500), or 250 mg/kg of GRA mixed with same dose of MF (GM250) for 3 weeks. Blood glucose level and body weight were measured every 5th day. G500 and M500 both significantly reduced blood glucose levels as compared to the diabetic control group (diabetic control, 458.3$\pm$25.4 mg/dl; G500, 275.0$\pm$12.0; M500, 278.0$\pm$15.4; GM250, 324.0$\pm$18.4). While body weight in diabetic control group was decreased slightly after 3 weeks, treatment groups showed gradual increases of body weight during 3 week-period. Plasma insulin level was increased by treatment with GRA, but those levels in M500 and GM250 groups were similar to the diabetic control (normal control, 32.0$\pm$13.9 $\mu$IU/mι; diabetic control, 12.4$\pm$1.9; G500, 17.5$\pm$3.4; M500, 11.1$\pm$3.2; GM250, 10.5$\pm$t3.7). Urine glucose levels were also remarkably reduced in all treatment groups (normal control, 0.0$\pm$0.0 g/day; diabetic control, 11.4$\pm$2.5; G500, 4.9$\pm$0.2; M500, 5.7$\pm$1.6 ; GM250, 8.2$\pm$0.2). At the second and third week of the treatment, food and water intakes were determined. At the third week, food and water intakes were significantly decreased in all treatment groups. Taken together, we may conclude that GRA and MF alone may prevent or delay the development of hyperglycemia, however, synergistic hypoglycemic activity was not be seen in group treated with mixed formula of GRA and MF when compared to GRA or MF alone.

The outcome of percutaneous stent implantation in congenital heart disease: experience of a single institute

  • Kim, Moon Sun;Yoon, Ja Kyoung;Kim, Seong Ho;Bang, Ji Seok;Jang, So Ick;Lee, Sang Yoon;Choi, Eun Young;Park, Su Jin;Kwon, Hye Won
    • Clinical and Experimental Pediatrics
    • /
    • 제61권6호
    • /
    • pp.187-193
    • /
    • 2018
  • Purpose: The efficacy of percutaneous stent implantation for congenital heart disease (CHD) in Korea, where stent availability is limited, has not been determined. This study evaluated the acute and midterm results of stent implantation in different CHD subgroups. Methods: Stents were implanted in 75 patients with 81 lesions: (1) pulmonary artery stenosis (PAS) group, 56 lesions in 51 patients; (2) coarctation of the aorta (CoA) group, 5 lesions in 5 patients; (3) Fontan group, 13 lesions in 12 patients; (4) ductal stent group, 3 lesions in 3 patients; and (5) other CHD group, 4 lesions in 4 patients. Mean follow-up duration was 2.1 years (0.1-4 years). Medical records were reviewed retrospectively. Results: The minimum lumen diameter (MLD) in PAS and CoA increased from $5.0{\pm}1.9mm$ and $8.4{\pm}1.6mm$ to $10.1{\pm}3.6mm$ and $12.3{\pm}2.5mm$, respectively (P<0.01). In the PAS group, pressure gradient decreased from $25.7{\pm}15.6mmHg$ to $10.4{\pm}10.1mmHg$, and right ventricular to aortic pressure ratio from $0.56{\pm}0.21$ to $0.46{\pm}0.19$. In the CoA group, the pressure gradient decreased from $50{\pm}33mmHg$ to $17{\pm}8mmHg$. In the ductal stent group, the MLD of the ductus increased from 2.3 mm to 4.3 mm and arterial oxygen saturation from 40%-70% to 90%. No deaths were associated with stent implantation. Stent migration occurred in 3 patients, but repositioning was successful in all. Stent redilation was performed successfully in 26 cases after $29{\pm}12months$. Conclusion: Percutaneous stent implantation was safe and effective, with acceptable short and mid-term outcomes in Korean CHD patients.

뉴캣슬병 면역에 대한 검토 III. 예방접종 프로그램과 접종경노를 중심으로 한 뉴캣슬병 면역능 검토 (Studies on the Immunization Against Newcastle Disease III. Investions on the Immunity of Newcatle Disease with Special Reference to Vaccination Program and Route)

  • 이학철;정유열
    • 한국가금학회지
    • /
    • 제8권2호
    • /
    • pp.77-89
    • /
    • 1981
  • The experimental study was undertaken to confirm the effect of vaccination of birds with Newcastle disease (ND) vaccines on the Market by use of th. various vaccination programs. Sixteen groups of birds varying from 2 to f days of age, which were originated from hyper-immunised hens against ND were immunised by three different ways, a live vaccine only, a killed vaccine only, and the combination of a live and killed vaccine according to the each schedule of employed programs. In the administration of a live vaccine only, birds were immunized by one of following methods, the combination of intranasal and intraocular inoculation, intramuscular inoculation, via drinking water and the double inoculation by spray and drinking water application. Except for the double application, all the birds were vaccinated 2,3 or 4 times with two volumes of the virus dose (drinking water application) instructed by the commercial vaccine laboratory, until 21, 28 or 30 days of age, and all the immunized birds 19, 21 or 28 days postvaccination were challenged intramuscularly with 1.0$m\ell$ of 10,000 MLD per $m\ell$ of a virulent ND virus. In the administration of the combination of a live and killed vaccine, birds were immunized 2 or 3 times intranasally at first until 14 or 28 days of age with the same dose of the above experiment of a live vaccine, and then inoculated intramuscularly 1 or 2 times until 60 days of age with 1.0 $m\ell$ of a killed vaccine. And all immunized birds 11 days postvaccination were challenged with the same procedure of the above experiment. In the administration of a killed vaccine only, birds were immunized 3 times intramuscularly until 28 days of age with varied dose (0.2-0.5 $m\ell$) of a killed vaccine and all immunized birds 33 days postvaccination were challenged with the same procedure of the above experiment. The results obtained are summerised as follows: All birds vaccinated by using the combination of a live and killed vaccine program or a killed vaccin only appeared to be refractory. without any sign of illness, to the challenge exposure with 1.0$m\ell$ of 10,000 MLD per $m\ell$ of a virulent ND virus. On the other hand, the survival rates of birds of live vaccine groups immunized by a number of vaccine program such as Salsbury's day old program, 3-3-3 program, the Institute of Veterinary Reserch program and Multiple inoculation program, were 39.58%, 43.7%, 43.75% and 47.80%, respectively. And the survival rates of birds vaccinated with a live vaccine by 4 different ways of administration, i.e., double inoculation by water and aerosol application, intramuscular injection, intranasal instillation and via 4.inking water were 87.50%, 64.06%, 42.18% and 25.00%, respectively.

  • PDF

A System Level Network-on-chip Model with MLDesigner

  • Agarwal, Ankur;Shankar, Rabi;Pandya, A.S.;Lho, Young-Uhg
    • Journal of information and communication convergence engineering
    • /
    • 제6권2호
    • /
    • pp.122-128
    • /
    • 2008
  • Multiprocessor architectures and platforms, such as, a multiprocessor system on chip (MPSoC) recently introduced to extend the applicability of the Moore's law, depend upon concurrency and synchronization in both software and hardware to enhance design productivity and system performance. With the rapidly approaching billion transistors era, some of the main problem in deep sub-micron technologies characterized by gate lengths in the range of 60-90 nm will arise from non scalable wire delays, errors in signal integrity and non-synchronized communication. These problems may be addressed by the use of Network on Chip (NOC) architecture for future System-on-Chip (SoC). We have modeled a concurrent architecture for a customizable and scalable NOC in a system level modeling environment using MLDesigner (from MLD Inc.). Varying network loads under various traffic scenarios were applied to obtain realistic performance metrics. We provide the simulation results for latency as a function of the buffer size. We have abstracted the area results for NOC components from its FPGA implementation. Modeled NOC architecture supports three different levels of quality-of-service (QoS).

연강과 스프링압을 접합한 층상복합 강재의 피로파괴거동에 대한 연구 (Fatigue Fracture Behavior of Laminated Steel with Mild Steel and Spring Steel)

  • 김영진;신창균
    • 대한기계학회논문집
    • /
    • 제2권3호
    • /
    • pp.53-61
    • /
    • 1978
  • This study has been concentrated on the relations between the crack growth rate and the stress intensity factor, the fatigue limit and finally on the condition of the crack propagation along the laminated cross section of the laminated steel under the repeated plane bending through tests. The following results are obtained. 1. The fatigue limit of the laminated steel is higher than the single steel 2. The realtion between the fatigue crack growth rate, dL/dN and Stress intensity factor are ; dL/dN = 2.14 * 10$^{-11}$ $K^{2.95}$ for SUP 9 dL/dN = 1.70 * 10$^{-11}$ $K^{2.95}$ for SMS dL/dN = 9.77 * 10$^{-11}$ $K^{2.95}$ for SPMS dL/dN = 3.57 * 10$^{-8}$ $K^{1.53}$ for SPMM dL/dN = 5.5O * 10$^{-8}$ $K^{1.53}$ for MLD 3. The crack propagation of the laminated steel also tends to be completed through 3 steps; The first step proceeds swiftly, in a second slowly for a long time and last very rapidly for a short moments.

타우린의 뼈 형성 작용과 관련질환의 경감 (Taurine in Bone Formation and Alleviation of Its Diseases)

  • 김미향;;김성진
    • Biomolecules & Therapeutics
    • /
    • 제10권3호
    • /
    • pp.137-141
    • /
    • 2002
  • Taurine, amino acid, chemically known as 2-amino ethane sulphonic acid was discovered more than two hundred years ago from ox bile. it is widely distributed in both mammals and nonmammals. It is found in considerably high amount in hUl11an: a normal adult of 70 kgs contains about 70 grams of taurine. Taurine with this much concentration, is involved in almost all life processes. Its deficiency causes several abnormalities in major organs like brain, eye and heart. Taurine-bone interaction is latest addition to its long list of actions. In bone cells, taurine is also found in high concentration. Taurine is found to help in enhancing the bone tissue formation which is evidenced by increased matrix formation and collagen synthesis. Besides stimulating the bone tissue formation, it also inhibits the bone loss through inhibiting the bone resorption and osteoclast formation. Thus, taurine acts as a double agent. In addition to these two major actions of taurine in bone, it also has beneficial effect in wound healing mld bone repair. Taurine possess radioprotective properties, too. As it is a naturally available molecule, it can be used as a preventive agent. Taurine has a potential to replace bisphosphonates which are currently in use for the inhibition of bone loss but this needs in depth study. As taurine is involved in bone formation and inhibition of bone loss, a detailed study can make it a single marker of bone metabolism. All these taurine-bone interaction is a symbol of their deep involvement but still require further extension to make taurine as a choice for tile sound bone health.